ื‘ื—ืจื• ืขืžื•ื“

ื“ื‘ืจื™ื ื˜ื•ื‘ื™ื ื‘ืื™ื ื‘-3!

ื ื™ืงื•ืœื•, ืืœืกื ื“ืจื• ื•ืกืžื™ ื ืžื ื™ื ืขื ื›ืžืขื˜ 100 ื™ืœื“ื™ื ื•ืžื‘ื•ื’ืจื™ื ืฆืขื™ืจื™ื ืขื ืคืจื•ื’ืจื™ื” ื‘ืจื—ื‘ื™ ื”ืขื•ืœื ืฉื ื”ื ื™ื ืžืชืจื•ืคืช ืœื•ื ืคืจื ื™ื‘ ืžืืจื™ื›ืช ื—ื™ื™ื, ื”ืžืื•ืฉืจืช ืขืœ ื™ื“ื™ ื”-FDA. PRF ื™ืžืฉื™ืš ืœื”ืงื“ื™ืฉ ื›ืกืคื™ื ื›ื“ื™ ืœื”ื‘ื˜ื™ื— ื’ื™ืฉื” ืœืœื•ื ืคืจื ื™ื‘ ืœื›ื•ืœื, ื•ืœื—ืงื•ืจ ืืช ื”ืฉืคืขื•ืชื™ื• ืืจื•ื›ื•ืช ื”ื˜ื•ื•ื—.

ืื‘ืœ ืœื ื ืขืฆื•ืจ ืฉื.

 

PRF ื‘ื•ื—ืŸ 3 ืึทื—ึตืจ ืžืกืœื•ืœื™ื ื˜ื™ืคื•ืœื™ื™ื

ื›ื“ื™ ืœื˜ืคืœ ื•ืœืจืคื ืคืจื•ื’ืจื™ื”, ืœืชืงื•ืฃ ืžื—ืœื” ื–ื•:

ื‘- ื—ึถืœึฐื‘ึผื•ึนืŸ, ื‘- RNA, ื•ื‘- DNA ืจืžื•ืช!

ืชืจื•ืคื•ืช ืžื•ืœืงื•ืœื•ืช ืงื˜ื ื•ืช

ืื™ืš ื–ื” ืขื•ื‘ื“? ื”ื˜ื™ืคื•ืœ ื”ื–ื” ืžืคื—ื™ืช ืจืžืช ื—ืœื‘ื•ืŸ ื”ืคืจื•ื’ืจื™ืŸ ื”ืจืขื™ืœ ืฉื’ื•ืจื ืœืคืจื•ื’ืจื™ื”.

ืžื” ืชืคืงื™ื“ื• ืฉืœ PRF? PRF ืžืฉืชืคืช ืคืขื•ืœื” ืขื ื—ื‘ืจืช ื”ื‘ื™ื•ื˜ืง PRGS&T ื›ื“ื™ ืœื”ืชื—ื™ืœ ื‘ื ื™ืกื•ื™ ืงืœื™ื ื™ ื—ื“ืฉ ืฉื‘ื•ื“ืง ื”ืื Ionafarnib, ื‘ืฉื™ืœื•ื‘ ืขื ืชืจื•ืคื” ื—ื“ืฉื” ื‘ืฉื ืคืจื•ื’ืจื™ื ื™ืŸ, ื™ืขื™ืœื” ื™ื•ืชืจ ืžืืฉืจ Ionafarnib ืœื‘ื“ื”.

ืœืžื” ื–ื” ืžื‘ื˜ื™ื—? ืชืจื•ืคื” ื—ื“ืฉื” ื–ื• ื”ื’ื“ื™ืœื” ืืช ืชื•ื—ืœืช ื”ื—ื™ื™ื ื‘ื“ื’ื ืขื›ื‘ืจ ืคืจื•ื’'ืจื™ื” ืขืœ ื™ื“ื™ 50%.

RNA Therapeutics

ืื™ืš ื–ื” ืขื•ื‘ื“? ื”ื˜ื™ืคื•ืœ ื”ื–ื” ื—ื•ืกื ืืช ื™ื™ืฆื•ืจ ืคืจื•ื’ืจื™ืŸ ื‘ืจืžืช ื”-RNA, ืœืคื ื™ ืฉื”ื—ืœื‘ื•ืŸ ื”ืจืขื™ืœ ื ื•ืฆืจ ืขืœ ื™ื“ื™ ืชืื™ ื”ื’ื•ืฃ.

ืžื” ืชืคืงื™ื“ื• ืฉืœ PRF? PRF ื”ื•ื ืžืคืชื— ื”ืชืจื•ืคื” (ืื• "ื ื•ืชืŸ ื”ื—ืกื•ืช"). ื”ืžืฉืžืขื•ืช ื”ื™ื ืฉ-PRF ืœื•ืงื— ืขืœ ืขืฆืžื• ืื—ืจื™ื•ืช ื•ืขืœื•ื™ื•ืช ืœื™ื™ืฆื•ืจ ืชืจื•ืคื•ืช, ืžื—ืงืจื™ื ืงื“ื ื ื™ืกื•ื™ื™ื ื‘ื‘ืขืœื™ ื—ื™ื™ื ื•ืชืื™, ื•ื ื™ืกื•ื™ื™ื ืงืœื™ื ื™ื™ื ืฉื ืขืจื›ื• ืขืœ ื™ื“ื™ ืžื•ืžื—ื™ื ืžื“ืขื™ื™ื ื‘ืจืžื” ืขื•ืœืžื™ืช.

ืœืžื” ื–ื” ืžื‘ื˜ื™ื—? ื”ื˜ื™ืคื•ืœ ื‘-RNA ื”ื‘ื™ื ืœ- 62% ืขืœื™ื™ื” ื‘ืชื•ื—ืœืช ื”ื—ื™ื™ื ืฉืœ ืขื›ื‘ืจ ืคืจื•ื’ืจื™ื”.

ืขืจื™ื›ืช ื‘ืกื™ืก DNA

ืื™ืš ื–ื” ืขื•ื‘ื“? ืชืจื•ืคื” ื–ื• ืชื™ื›ื ืก ืœืชืื™ ื”ื’ื•ืฃ, ืœืžืฆื•ื ืืช ื”ืžื•ื˜ืฆื™ื” ืฉืœ ืคืจื•ื’ืจื™ื”, ื• ืœืชืงืŸ ืืช ื–ื” ืœืฆืžื™ืชื•ืช. ื”ืชื ื”ืขืจื•ืš ื›ื‘ืจ ืœื ื™ื™ืฆื•ืจ ืฉื•ื ืคืจื•ื’ืจื™ืŸ - WOW!

ืžื” ืชืคืงื™ื“ื• ืฉืœ PRF? PRF ืชืžืžืŸ ื™ื™ืฆื•ืจ ืชืจื•ืคื•ืช, ืžื—ืงืจื™ื ืงื“ื ื ื™ืกื•ื™ื™ื ื‘ื‘ืขืœื™ ื—ื™ื™ื ื•ืชืื™, ื•ื ื™ืกื•ื™ื™ื ืงืœื™ื ื™ื™ื ืฉื ืขืจื›ื• ืขืœ ื™ื“ื™ ืžื•ืžื—ื™ื ืžื“ืขื™ื™ื ื‘ืจืžื” ืขื•ืœืžื™ืช.

ืœืžื” ื–ื” ืžื‘ื˜ื™ื—? ื‘ื“ื’ื ืขื›ื‘ืจ ืคืจื•ื’'ืจื™ื”, ืชื•ื—ืœืช ื”ื—ื™ื™ื ื”ื•ืืจืš ื‘- 140%, ืžืชืงืจื‘ ืœืžื” ืฉื”ื•ื ื‘ื“ืจืš ื›ืœืœ ื–ืงื ื” ืขื‘ื•ืจ ืขื›ื‘ืจื™ื ื‘ืจื™ืื™ื. ื–ื• ื–ืจื™ืงื” ื—ื“ ืคืขืžื™ืช ืฉื™ื›ื•ืœื” ืœื”ื™ื•ืช ืฉืœื ื• ืžืกืœื•ืœ ืืœ ื”-CURE!

ืžื“ืข ื”ื•ื ืžืืžืฅ ื™ืงืจ, ื•ืขื ืชืžื™ื›ืชืš ื”ืžืชืžืฉื›ืช, ื ืžืฉื™ืš ื‘ื›ืš

ืœื“ื—ื•ืฃ ืืช ื’ื‘ื•ืœื•ืช ื”ืžื“ืข ืœืขื‘ืจ ื”ืชืจื•ืคื”.

ืฆื•ื•ืช ืงื™ื™ืœื™

ืฆื•ื•ืช ื–ื•ืื™

ย 

ย 

ืฆื•ื•ืช ื ืชืŸ ื•ื‘ื ื˜

ืฆื•ื•ืช PRF

ืชื•ื“ื” ืขืœ ืชืžื™ื›ืชืš ื”ื ื“ื™ื‘ื”. ื‘ื™ื—ื“, ืื ื—ื ื• ืจึธืฆื•ึนืŸ ืœืžืฆื•ื ืืช ื”ืชืจื•ืคื”!

he_ILHebrew